{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T20:03:06Z","timestamp":1787169786125,"version":"build-2736575974"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:00:00Z","timestamp":1769817600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100016714","name":"University of Sharjah","doi-asserted-by":"publisher","award":["25010901180"],"award-info":[{"award-number":["25010901180"]}],"id":[{"id":"10.13039\/100016714","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Diagn Ther"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1007\/s40291-026-00833-w","type":"journal-article","created":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T09:15:25Z","timestamp":1769850925000},"page":"321-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Neuromuscular Junction as a Molecular Target in Sarcopenia: Mechanisms, Therapeutic Strategies, and Future Directions"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8485-7172","authenticated-orcid":false,"given":"Rizwan","family":"Qaisar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Firdos","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asima","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,31]]},"reference":[{"issue":"18","key":"833_CR1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e146","volume":"37","author":"MR Cho","year":"2022","unstructured":"Cho MR, Lee S, Song SK. A review of sarcopenia pathophysiology, diagnosis, treatment and future direction. J Korean Med Sci. 2022;37(18):e146.","journal-title":"J Korean Med Sci"},{"key":"833_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2023.155533","volume":"144","author":"S Yuan","year":"2023","unstructured":"Yuan S, Larsson SC. Epidemiology of sarcopenia: prevalence, risk factors, and consequences. Metabolism. 2023;144:155533.","journal-title":"Metabolism"},{"issue":"1","key":"833_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.4103\/NRR.NRR-D-23-02055","volume":"20","author":"M Fujitani","year":"2025","unstructured":"Fujitani M, Tarif AMM, Otani Y. Regeneration mechanisms and therapeutic strategies for neuromuscular junctions in aging and diseases. Neural Regen Res. 2025;20(1):193\u20134.","journal-title":"Neural Regen Res"},{"issue":"1","key":"833_CR4","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.15917","volume":"12","author":"Y Miao","year":"2024","unstructured":"Miao Y, et al. Unraveling the causes of sarcopenia: roles of neuromuscular junction impairment and mitochondrial dysfunction. Physiol Rep. 2024;12(1):e15917.","journal-title":"Physiol Rep"},{"issue":"2-3","key":"833_CR5","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.exger.2010.08.029","volume":"46","author":"YC Jang","year":"2011","unstructured":"Jang YC, Van Remmen H. Age-associated alterations of the neuromuscular junction. Exp Gerontol. 2011;46(2\u20133):193\u20138.","journal-title":"Exp Gerontol"},{"key":"833_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.exger.2021.111613","volume":"156","author":"SK Burke","year":"2021","unstructured":"Burke SK, et al. Variation in muscle and neuromuscular junction morphology between atrophy-resistant and atrophy-prone muscles supports failed re-innervation in aging muscle atrophy. Exp Gerontol. 2021;156:111613.","journal-title":"Exp Gerontol"},{"key":"833_CR7","doi-asserted-by":"crossref","unstructured":"Cui C, et al. Exploring motor unit and neuromuscular junction dysfunction in aging and sarcopenia: insights from electromyography in systematic review. Geroscience. 2025.","DOI":"10.1007\/s11357-025-01760-0"},{"issue":"3","key":"833_CR8","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1152\/physrev.00033.2014","volume":"95","author":"LA Tintignac","year":"2015","unstructured":"Tintignac LA, Brenner HR, Ruegg MA. Mechanisms regulating neuromuscular junction development and function and causes of muscle wasting. Physiol Rev. 2015;95(3):809\u201352.","journal-title":"Physiol Rev"},{"key":"833_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2023.101966","volume":"89","author":"WD Arnold","year":"2023","unstructured":"Arnold WD, Clark BC. Neuromuscular junction transmission failure in aging and sarcopenia: the nexus of the neurological and muscular systems. Ageing Res Rev. 2023;89:101966.","journal-title":"Ageing Res Rev"},{"key":"833_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2020.610964","volume":"13","author":"PM Rodriguez Cruz","year":"2020","unstructured":"Rodriguez Cruz PM, et al. The neuromuscular junction in health and disease: molecular mechanisms governing synaptic formation and homeostasis. Front Mol Neurosci. 2020;13:610964.","journal-title":"Front Mol Neurosci"},{"key":"833_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122186","volume":"333","author":"R Qaisar","year":"2023","unstructured":"Qaisar R. Targeting neuromuscular junction to treat neuromuscular disorders. Life Sci. 2023;333:122186.","journal-title":"Life Sci"},{"key":"833_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061307","author":"G Dobrowolny","year":"2021","unstructured":"Dobrowolny G, et al. Age-related alterations at neuromuscular junction: role of oxidative stress and epigenetic modifications. Cells. 2021. https:\/\/doi.org\/10.3390\/cells10061307.","journal-title":"Cells"},{"issue":"9","key":"833_CR13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.3003388","volume":"23","author":"B Mallik","year":"2025","unstructured":"Mallik B, et al. Mitochondrial complex I and ROS control neuromuscular function through opposing pre- and postsynaptic mechanisms. PLoS Biol. 2025;23(9):e3003388.","journal-title":"PLoS Biol"},{"key":"833_CR14","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.nbd.2013.03.005","volume":"55","author":"E Ydens","year":"2013","unstructured":"Ydens E, et al. The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis. 2013;55:95\u2013103.","journal-title":"Neurobiol Dis"},{"key":"833_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.948819","volume":"10","author":"YF Chen","year":"2022","unstructured":"Chen YF, et al. Immunometabolism of macrophages regulates skeletal muscle regeneration. Front Cell Dev Biol. 2022;10:948819.","journal-title":"Front Cell Dev Biol"},{"key":"833_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.rmed.2025.108458","volume":"249","author":"R Qaisar","year":"2025","unstructured":"Qaisar R, Khan I, Ahmad F, Karim A. Smoking cessation improves neuromuscular health and respiratory sarcopenia in older male adults over one year. Respir Med. 2025;249:1\u201311.","journal-title":"Respir Med"},{"issue":"3 Pt 2","key":"833_CR17","first-page":"21","volume":"112","author":"M Martynov","year":"2012","unstructured":"Martynov M, et al. Neuroprotective treatment with citicoline (ceraxon) in patients with ischemic stroke. Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(3 Pt 2):21\u20136.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"3","key":"833_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jstrokecerebrovasdis.2008.01.006","volume":"17","author":"F Iranmanesh","year":"2008","unstructured":"Iranmanesh F, Vakilian A. Efficiency of citicoline in increasing muscular strength of patients with nontraumatic cerebral hemorrhage: a double-blind randomized clinical trial. J Stroke Cerebrovasc Dis. 2008;17(3):153\u20135.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"833_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1179\/1743132812Y.0000000003","volume":"34","author":"B Caner","year":"2012","unstructured":"Caner B, et al. Intraperitoneal administration of CDP-choline or a combination of cytidine plus choline improves nerve regeneration and functional recovery in a rat model of sciatic nerve injury. Neurol Res. 2012;34(3):238\u201345.","journal-title":"Neurol Res"},{"issue":"14","key":"833_CR20","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1016\/j.addr.2009.06.009","volume":"61","author":"MG Rosca","year":"2009","unstructured":"Rosca MG, Lemieux H, Hoppel CL. Mitochondria in the elderly: is acetylcarnitine a rejuvenator? Adv Drug Deliv Rev. 2009;61(14):1332\u201342.","journal-title":"Adv Drug Deliv Rev"},{"issue":"11","key":"833_CR21","doi-asserted-by":"publisher","first-page":"5344","DOI":"10.1007\/s00415-023-11844-6","volume":"270","author":"S Sassi","year":"2023","unstructured":"Sassi S, et al. Retrospective observational study on the use of acetyl-l-carnitine in ALS. J Neurol. 2023;270(11):5344\u201357.","journal-title":"J Neurol"},{"issue":"1","key":"833_CR22","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0047-6374(95)01651-1","volume":"85","author":"C De Angelis","year":"1995","unstructured":"De Angelis C, et al. Age- and trauma-dependent modifications of neuromuscular junction and skeletal muscle structure in the rat. Effects of long-term treatment with Acetyl-l-Carnitine. Mech Ageing Dev. 1995;85(1):37\u201353.","journal-title":"Mech Ageing Dev"},{"issue":"7","key":"833_CR23","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/j.bjps.2009.05.039","volume":"63","author":"AD Wilson","year":"2010","unstructured":"Wilson AD, et al. Acetyl-l-carnitine increases nerve regeneration and target organ reinnervation\u2014a morphological study. J Plast Reconstr Aesthet Surg. 2010;63(7):1186\u201395.","journal-title":"J Plast Reconstr Aesthet Surg"},{"issue":"3","key":"833_CR24","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1002\/mus.21485","volume":"41","author":"PJ Apel","year":"2010","unstructured":"Apel PJ, et al. Effect of locally delivered IGF-1 on nerve regeneration during aging: an experimental study in rats. Muscle Nerve. 2010;41(3):335\u201341.","journal-title":"Muscle Nerve"},{"issue":"9","key":"833_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41419-023-06128-w","volume":"14","author":"H Ishihara","year":"2023","unstructured":"Ishihara H, et al. Blocking insulin-like growth factor 1 receptor signaling pathway inhibits neuromuscular junction regeneration after botulinum toxin-A treatment. Cell Death Dis. 2023;14(9):609.","journal-title":"Cell Death Dis"},{"key":"833_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22010136","author":"S Stanga","year":"2020","unstructured":"Stanga S, Boido M, Kienlen-Campard P. How to build and to protect the neuromuscular junction: the role of the glial cell line-derived neurotrophic factor. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms22010136.","journal-title":"Int J Mol Sci"},{"issue":"Suppl 1","key":"833_CR27","doi-asserted-by":"publisher","first-page":"S82","DOI":"10.1097\/00002093-200000001-00013","volume":"14","author":"T Nishizaki","year":"2000","unstructured":"Nishizaki T, et al. Presynaptic nicotinic acetylcholine receptors as a functional target of nefiracetam in inducing a long-lasting facilitation of hippocampal neurotransmission. Alzheimer Dis Assoc Disord. 2000;14(Suppl 1):S82\u201394.","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"833_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2023.1188839","volume":"17","author":"S Bagheri","year":"2023","unstructured":"Bagheri S, et al. Neuroprotective effects of coenzyme Q10 on neurological diseases: a review article. Front Neurosci. 2023;17:1188839.","journal-title":"Front Neurosci"},{"key":"833_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2022.136669","volume":"781","author":"J Zhang","year":"2022","unstructured":"Zhang J, et al. Alpha-lipoic acid improved motor function in MPTP-induced Parkinsonian mice by reducing neuroinflammation in the nigral and spinal cord. Neurosci Lett. 2022;781:136669.","journal-title":"Neurosci Lett"},{"key":"833_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnagi.2020.597811","volume":"12","author":"Z Bao","year":"2020","unstructured":"Bao Z, Cui C, Chow S, Qin L, Wong R, Cheung W. AChRs degeneration at NMJ in aging-associated sarcopenia\u2014a systematic review. Front Aging Neurosci. 2020;12:1\u201316.","journal-title":"Front Aging Neurosci"},{"issue":"6","key":"833_CR31","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.neuint.2012.02.028","volume":"61","author":"MP Daniels","year":"2012","unstructured":"Daniels MP. The role of agrin in synaptic development, plasticity and signaling in the central nervous system. Neurochem Int. 2012;61(6):848\u201353.","journal-title":"Neurochem Int"},{"issue":"3","key":"833_CR32","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41419-024-06581-1","volume":"15","author":"J Chen","year":"2024","unstructured":"Chen J, et al. Deficiency of skeletal muscle agrin contributes to the pathogenesis of age-related sarcopenia in mice. Cell Death Dis. 2024;15(3):201.","journal-title":"Cell Death Dis"},{"issue":"2","key":"833_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0088739","volume":"9","author":"S Hettwer","year":"2014","unstructured":"Hettwer S, et al. Injection of a soluble fragment of neural agrin (NT-1654) considerably improves the muscle pathology caused by the disassembly of the neuromuscular junction. PLoS ONE. 2014;9(2):e88739.","journal-title":"PLoS ONE"},{"key":"833_CR34","doi-asserted-by":"publisher","first-page":"17","DOI":"10.3389\/fncel.2018.00017","volume":"12","author":"M Boido","year":"2018","unstructured":"Boido M, et al. Increasing agrin function antagonizes muscle atrophy and motor impairment in spinal muscular atrophy. Front Cell Neurosci. 2018;12:17.","journal-title":"Front Cell Neurosci"},{"key":"833_CR35","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1146\/annurev-bioeng-071114-040640","volume":"17","author":"N Bursac","year":"2015","unstructured":"Bursac N, Juhas M, Rando TA. Synergizing engineering and biology to treat and model skeletal muscle injury and disease. Annu Rev Biomed Eng. 2015;17:217\u201342.","journal-title":"Annu Rev Biomed Eng"},{"key":"833_CR36","doi-asserted-by":"crossref","unstructured":"Li X, et al. Role of Agrin in tissue repair and regeneration: From mechanisms to therapeutic opportunities (Review). Int J Mol Med. 2024;54(5):1\u201312.","DOI":"10.3892\/ijmm.2024.5422"},{"key":"833_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1146\/annurev-physiol-022516-034255","volume":"80","author":"L Li","year":"2018","unstructured":"Li L, Xiong WC, Mei L. Neuromuscular junction formation, aging, and disorders. Annu Rev Physiol. 2018;80:159\u201388.","journal-title":"Annu Rev Physiol"},{"key":"833_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135014","volume":"731","author":"LA Fish","year":"2020","unstructured":"Fish LA, Fallon JR. Multiple MuSK signaling pathways and the aging neuromuscular junction. Neurosci Lett. 2020;731:135014.","journal-title":"Neurosci Lett"},{"issue":"3","key":"833_CR39","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.celrep.2012.08.004","volume":"2","author":"MJ Perez-Garcia","year":"2012","unstructured":"Perez-Garcia MJ, Burden SJ. Increasing MuSK activity delays denervation and improves motor function in ALS mice. Cell Rep. 2012;2(3):497\u2013502.","journal-title":"Cell Rep"},{"issue":"1","key":"833_CR40","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1038\/nn2026","volume":"11","author":"N Kim","year":"2008","unstructured":"Kim N, Burden SJ. MuSK controls where motor axons grow and form synapses. Nat Neurosci. 2008;11(1):19\u201327.","journal-title":"Nat Neurosci"},{"issue":"10","key":"833_CR41","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.nmd.2022.09.002","volume":"32","author":"L Remijn-Nelissen","year":"2022","unstructured":"Remijn-Nelissen L, Verschuuren J, Tannemaat MR. The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study. Neuromuscul Disord. 2022;32(10):790\u20139.","journal-title":"Neuromuscul Disord"},{"key":"833_CR42","doi-asserted-by":"crossref","unstructured":"Tezze C, et al. A combination of metformin and galantamine exhibits synergistic benefits in the treatment of sarcopenia. JCI Insight. 2023;8(15):1\u201316.","DOI":"10.1172\/jci.insight.168787"},{"key":"833_CR43","doi-asserted-by":"crossref","unstructured":"Londzin P, et al. Effects of donepezil on the musculoskeletal system in female rats. Int J Mol Sci. 2023;24(10):1\u201323.","DOI":"10.3390\/ijms24108991"},{"issue":"3","key":"833_CR44","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1177\/2042098617750555","volume":"9","author":"R Khoury","year":"2018","unstructured":"Khoury R, Rajamanickam J, Grossberg GT. An update on the safety of current therapies for Alzheimer\u2019s disease: focus on rivastigmine. Ther Adv Drug Saf. 2018;9(3):171\u20138.","journal-title":"Ther Adv Drug Saf"},{"issue":"2","key":"833_CR45","doi-asserted-by":"publisher","first-page":"893","DOI":"10.14336\/AD.2023.0713-1","volume":"15","author":"R Schellino","year":"2024","unstructured":"Schellino R, et al. Synergistically acting on myostatin and agrin pathways increases neuromuscular junction stability and endurance in old mice. Aging Dis. 2024;15(2):893\u2013910.","journal-title":"Aging Dis"},{"issue":"9","key":"833_CR46","doi-asserted-by":"publisher","first-page":"6805","DOI":"10.1007\/s12035-024-03991-2","volume":"61","author":"CR Gafurova","year":"2024","unstructured":"Gafurova CR, et al. beta2-Adrenergic regulation of the neuromuscular transmission and its lipid-dependent switch. Mol Neurobiol. 2024;61(9):6805\u201321.","journal-title":"Mol Neurobiol"},{"issue":"19","key":"833_CR47","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1113\/JP289023","volume":"603","author":"M Hostrup","year":"2025","unstructured":"Hostrup M, et al. Clenbuterol induces lean mass and muscle protein accretion, but attenuates cardiorespiratory fitness and desensitizes muscle beta(2)-adrenergic signalling. J Physiol. 2025;603(19):5529\u201345.","journal-title":"J Physiol"},{"issue":"17","key":"833_CR48","doi-asserted-by":"publisher","first-page":"4121","DOI":"10.1113\/JP275560","volume":"596","author":"M Hostrup","year":"2018","unstructured":"Hostrup M, et al. Beta(2)-adrenoceptor agonist salbutamol increases protein turnover rates and alters signalling in skeletal muscle after resistance exercise in young men. J Physiol. 2018;596(17):4121\u201339.","journal-title":"J Physiol"},{"issue":"2","key":"833_CR49","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1007\/s13539-013-0125-7","volume":"5","author":"MS Potsch","year":"2014","unstructured":"Potsch MS, et al. The anabolic catabolic transforming agent (ACTA) espindolol increases muscle mass and decreases fat mass in old rats. J Cachexia Sarcopenia Muscle. 2014;5(2):149\u201358.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"833_CR50","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1002\/jcsm.12126","volume":"7","author":"AJ Stewart Coats","year":"2016","unstructured":"Stewart Coats AJ, et al. Espindolol for the treatment and prevention of cachexia in patients with stage III\/IV non-small cell lung cancer or colorectal cancer: a randomized, double-blind, placebo-controlled, international multicentre phase II study (the ACT-ONE trial). J Cachexia Sarcopenia Muscle. 2016;7(3):355\u201365.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"833_CR51","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1002\/jcsm.12191","volume":"8","author":"AL Clark","year":"2017","unstructured":"Clark AL, et al. Effect of beta-adrenergic blockade with carvedilol on cachexia in severe chronic heart failure: results from the COPERNICUS trial. J Cachexia Sarcopenia Muscle. 2017;8(4):549\u201356.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"833_CR52","doi-asserted-by":"crossref","unstructured":"Dolan E, et al. Muscular atrophy and sarcopenia in the elderly: is there a role for creatine supplementation? Biomolecules. 2019;9(11):1\u201313.","DOI":"10.3390\/biom9110642"},{"key":"833_CR53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241713519","author":"A Badu-Mensah","year":"2023","unstructured":"Badu-Mensah A, et al. The effect of skeletal muscle-specific creatine treatment on ALS NMJ integrity and function. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms241713519.","journal-title":"Int J Mol Sci"},{"issue":"10","key":"833_CR54","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1249\/MSS.0b013e3181a2c05c","volume":"41","author":"I Bazzucchi","year":"2009","unstructured":"Bazzucchi I, Felici F, Sacchetti M. Effect of short-term creatine supplementation on neuromuscular function. Med Sci Sports Exerc. 2009;41(10):1934\u201341.","journal-title":"Med Sci Sports Exerc"},{"issue":"2","key":"833_CR55","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1523\/JNEUROSCI.4595-09.2010","volume":"30","author":"EG Bruneau","year":"2010","unstructured":"Bruneau EG, Akaaboune M. Dynamics of the rapsyn scaffolding protein at the neuromuscular junction of live mice. J Neurosci. 2010;30(2):614\u20139.","journal-title":"J Neurosci"},{"issue":"6","key":"833_CR56","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.tins.2024.03.007","volume":"47","author":"RL Hastings","year":"2024","unstructured":"Hastings RL, Valdez G. Origin, identity, and function of terminal Schwann cells. Trends Neurosci. 2024;47(6):432\u201346.","journal-title":"Trends Neurosci"},{"issue":"38","key":"833_CR57","doi-asserted-by":"publisher","first-page":"9770","DOI":"10.1523\/JNEUROSCI.0174-16.2016","volume":"36","author":"A Barik","year":"2016","unstructured":"Barik A, et al. Schwann cells in neuromuscular junction formation and maintenance. J Neurosci. 2016;36(38):9770\u201381.","journal-title":"J Neurosci"},{"issue":"2","key":"833_CR58","doi-asserted-by":"publisher","first-page":"494","DOI":"10.14336\/AD.2020.0708","volume":"12","author":"S Fuertes-Alvarez","year":"2021","unstructured":"Fuertes-Alvarez S, Izeta A. Terminal Schwann cell aging: implications for age-associated neuromuscular dysfunction. Aging Dis. 2021;12(2):494\u2013514.","journal-title":"Aging Dis"},{"key":"833_CR59","doi-asserted-by":"publisher","DOI":"10.3390\/cells14010047","author":"KR Moss","year":"2025","unstructured":"Moss KR, Saxena S. Schwann cells in neuromuscular disorders: a spotlight on amyotrophic lateral sclerosis. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14010047.","journal-title":"Cells"},{"key":"833_CR60","doi-asserted-by":"publisher","first-page":"1603752","DOI":"10.3389\/fcell.2025.1603752","volume":"13","author":"AA Alhamdi","year":"2025","unstructured":"Alhamdi AA, et al. Pharmacologically targeting Schwann cells to improve regeneration following nerve damage. Front Cell Dev Biol. 2025;13:1603752.","journal-title":"Front Cell Dev Biol"},{"issue":"12","key":"833_CR61","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1038\/mt.2008.197","volume":"16","author":"M Suzuki","year":"2008","unstructured":"Suzuki M, et al. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS. Mol Ther. 2008;16(12):2002\u201310.","journal-title":"Mol Ther"},{"key":"833_CR62","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25010512","author":"G Careccia","year":"2023","unstructured":"Careccia G, Mangiavini L, Cirillo F. Regulation of satellite cells functions during skeletal muscle regeneration: a critical step in physiological and pathological conditions. Int J Mol Sci. 2023. https:\/\/doi.org\/10.3390\/ijms25010512.","journal-title":"Int J Mol Sci"},{"key":"833_CR63","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.892749","volume":"13","author":"F Huo","year":"2022","unstructured":"Huo F, Liu Q, Liu H. Contribution of muscle satellite cells to sarcopenia. Front Physiol. 2022;13:892749.","journal-title":"Front Physiol"},{"issue":"3","key":"833_CR64","doi-asserted-by":"publisher","first-page":"594","DOI":"10.2174\/1570159X19666210924092627","volume":"20","author":"EK Akkol","year":"2022","unstructured":"Akkol EK, et al. Effects of natural products on neuromuscular junction. Curr Neuropharmacol. 2022;20(3):594\u2013610.","journal-title":"Curr Neuropharmacol"},{"issue":"9","key":"833_CR65","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.tins.2020.07.002","volume":"43","author":"A Gromova","year":"2020","unstructured":"Gromova A, La Spada AR. Harmony lost: cell-cell communication at the neuromuscular junction in motor neuron disease. Trends Neurosci. 2020;43(9):709\u201324.","journal-title":"Trends Neurosci"},{"key":"833_CR66","doi-asserted-by":"publisher","first-page":"288","DOI":"10.37349\/ent.2024.00083","volume":"1","author":"A Mead","year":"2024","unstructured":"Mead A, Deliba\u015f B, \u00d6nger M, Kaplan S. The potential positive effects of coenzyme Q10 on the regeneration of peripheral nerve injury. Explor Neuroprotective Ther. 2024;1:288\u201399.","journal-title":"Explor Neuroprotective Ther"},{"key":"833_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2022.113360","volume":"153","author":"A Alhusaini","year":"2022","unstructured":"Alhusaini A, et al. Acetyl-l-carnitine and\/or liposomal co-enzyme Q10 prevent propionic acid-induced neurotoxicity by modulating oxidative tissue injury, inflammation, and ALDH1A1-RA-RARalpha signaling in rats. Biomed Pharmacother. 2022;153:113360.","journal-title":"Biomed Pharmacother"},{"key":"833_CR68","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.ebiom.2019.01.038","volume":"40","author":"E Pigna","year":"2019","unstructured":"Pigna E, et al. Histone deacetylase 4 protects from denervation and skeletal muscle atrophy in a murine model of amyotrophic lateral sclerosis. EBioMedicine. 2019;40:717\u201332.","journal-title":"EBioMedicine"},{"key":"833_CR69","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22158015","author":"Z Feng","year":"2021","unstructured":"Feng Z, et al. Activation of muscle-specific kinase (MuSK) reduces neuromuscular defects in the Delta7 mouse model of spinal muscular atrophy (SMA). Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22158015.","journal-title":"Int J Mol Sci"},{"key":"833_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116981","volume":"180","author":"S Bang","year":"2024","unstructured":"Bang S, et al. Metformin restores autophagic flux and mitochondrial function in late passage myoblast to impede age-related muscle loss. Biomed Pharmacother. 2024;180:116981.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"833_CR71","doi-asserted-by":"publisher","first-page":"F263","DOI":"10.1152\/ajprenal.00109.2010","volume":"301","author":"MC Fiore","year":"2011","unstructured":"Fiore MC, et al. Statins reverse renal inflammation and endothelial dysfunction induced by chronic high salt intake. Am J Physiol Renal Physiol. 2011;301(2):F263\u201370.","journal-title":"Am J Physiol Renal Physiol"},{"key":"833_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2023.107298","volume":"215","author":"R Qaisar","year":"2023","unstructured":"Qaisar R, et al. Degradation of neuromuscular junction contributes to muscle weakness but not physical compromise in chronic obstructive pulmonary disease patients taking lipids-lowering medications. Respir Med. 2023;215:107298.","journal-title":"Respir Med"},{"issue":"6","key":"833_CR73","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1023\/A:1019800703683","volume":"27","author":"S Dhitavat","year":"2002","unstructured":"Dhitavat S, et al. Acetyl-l-carnitine protects against amyloid-beta neurotoxicity: roles of oxidative buffering and ATP levels. Neurochem Res. 2002;27(6):501\u20135.","journal-title":"Neurochem Res"},{"issue":"3","key":"833_CR74","first-page":"121","volume":"4","author":"S Bhasin","year":"2015","unstructured":"Bhasin S. Selective androgen receptor modulators as function promoting therapies. J Frailty Aging. 2015;4(3):121\u20132.","journal-title":"J Frailty Aging"},{"key":"833_CR75","volume":"2011","author":"S Sato","year":"2011","unstructured":"Sato S, et al. Muscle plasticity and beta(2)-adrenergic receptors: adaptive responses of beta(2)-adrenergic receptor expression to muscle hypertrophy and atrophy. J Biomed Biotechnol. 2011;2011:729598.","journal-title":"J Biomed Biotechnol"},{"issue":"11","key":"833_CR76","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1093\/gerona\/glz292","volume":"75","author":"M Aubertin-Leheudre","year":"2020","unstructured":"Aubertin-Leheudre M, et al. Improved human muscle biopsy method to study neuromuscular junction structure and functions with aging. J Gerontol A Biol Sci Med Sci. 2020;75(11):2098\u2013102.","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"5","key":"833_CR77","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/s40291-024-00724-y","volume":"28","author":"R Qaisar","year":"2024","unstructured":"Qaisar R, et al. Tracking the plasma C-terminal agrin fragment as a biomarker of neuromuscular decline in 18- to 87-year-old men. Mol Diagn Ther. 2024;28(5):611\u201320.","journal-title":"Mol Diagn Ther"},{"issue":"2","key":"833_CR78","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/jcsm.13189","volume":"14","author":"E Monti","year":"2023","unstructured":"Monti E, et al. C-terminal agrin fragment as a biomarker of muscle wasting and weakness: a narrative review. J Cachexia Sarcopenia Muscle. 2023;14(2):730\u201344.","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"833_CR79","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.hrtlng.2025.09.022","volume":"75","author":"R Qaisar","year":"2026","unstructured":"Qaisar R, et al. Asthma-chronic obstructive pulmonary disease overlap is associated with a higher degree of neuromuscular junction degradation than either disease alone. Heart Lung. 2026;75:164\u201370.","journal-title":"Heart Lung"},{"issue":"7","key":"833_CR80","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157905","volume":"11","author":"A Daryadel","year":"2016","unstructured":"Daryadel A, et al. The C-terminal fragment of agrin (CAF), a novel marker of renal function, is filtered by the kidney and reabsorbed by the proximal tubule. PLoS ONE. 2016;11(7):e0157905.","journal-title":"PLoS ONE"},{"key":"833_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2025.1652698","volume":"12","author":"J Lv","year":"2025","unstructured":"Lv J, et al. Serum neurofilament light chain levels in myasthenia gravis patients with and without symptoms. Front Med (Lausanne). 2025;12:1652698.","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"833_CR82","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s13760-025-02759-2","volume":"125","author":"R Qaisar","year":"2025","unstructured":"Qaisar R, et al. Associations of plasma Neurofilament light chain with sarcopenia and physical capacity in patients with Alzheimer\u2019s diseases. Acta Neurol Belg. 2025;125(3):691\u20138.","journal-title":"Acta Neurol Belg"},{"issue":"4","key":"833_CR83","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.resinv.2024.04.014","volume":"62","author":"R Qaisar","year":"2024","unstructured":"Qaisar R, et al. Plasma levels of neurofilament light chain correlate with handgrip strength and sarcopenia in patients with chronic obstructive pulmonary disease. Respir Investig. 2024;62(4):566\u201371.","journal-title":"Respir Investig"},{"issue":"6","key":"833_CR84","first-page":"683","volume":"59","author":"J Lu","year":"2007","unstructured":"Lu J, Lichtman JW. Imaging the neuromuscular junction over the past centuries. Sheng Li Xue Bao. 2007;59(6):683\u201396.","journal-title":"Sheng Li Xue Bao"},{"issue":"6","key":"833_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.crmeth.2025.101082","volume":"5","author":"A Ramadan","year":"2025","unstructured":"Ramadan A, et al. Expansion microscopy reveals nano-scale insights into the human neuromuscular junction. Cell Rep Methods. 2025;5(6):101082.","journal-title":"Cell Rep Methods"},{"issue":"2","key":"833_CR86","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1021\/jacs.6b10727","volume":"139","author":"D Fu","year":"2017","unstructured":"Fu D, Yang W, Xie XS. Label-free imaging of neurotransmitter acetylcholine at neuromuscular junctions with stimulated Raman scattering. J Am Chem Soc. 2017;139(2):583\u20136.","journal-title":"J Am Chem Soc"},{"key":"833_CR87","doi-asserted-by":"crossref","unstructured":"Jarque-Bou NJ, Sancho-Bru JL, Vergara M. A systematic review of EMG applications for the characterization of forearm and hand muscle activity during activities of daily living: results, challenges, and open issues. Sensors (Basel); 2021, vol. 21, no. 9.","DOI":"10.3390\/s21093035"},{"issue":"3","key":"833_CR88","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/mus.24095","volume":"49","author":"H Nishimune","year":"2014","unstructured":"Nishimune H, Stanford JA, Mori Y. Role of exercise in maintaining the integrity of the neuromuscular junction. Muscle Nerve. 2014;49(3):315\u201324.","journal-title":"Muscle Nerve"},{"key":"833_CR89","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.jot.2024.03.007","volume":"46","author":"Q Wang","year":"2024","unstructured":"Wang Q, et al. Effects of physical exercise on neuromuscular junction degeneration during ageing: a systematic review. J Orthop Translat. 2024;46:91\u2013102.","journal-title":"J Orthop Translat"},{"key":"833_CR90","doi-asserted-by":"publisher","DOI":"10.2196\/58266","volume":"9","author":"M Stein","year":"2025","unstructured":"Stein M, et al. App- and wearable-based remote monitoring for patients with myasthenia gravis and its specialists: feasibility and usability study. JMIR Form Res. 2025;9:e58266.","journal-title":"JMIR Form Res"},{"issue":"4","key":"833_CR91","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s12031-022-01970-7","volume":"72","author":"A Karim","year":"2022","unstructured":"Karim A, et al. Evaluation of sarcopenia using biomarkers of the neuromuscular junction in Parkinson\u2019s disease. J Mol Neurosci. 2022;72(4):820\u20139.","journal-title":"J Mol Neurosci"}],"container-title":["Molecular Diagnosis & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40291-026-00833-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40291-026-00833-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:10:57Z","timestamp":1773825057000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40291-026-00833-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,31]]},"references-count":91,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s40291-026-00833-w","relation":{},"ISSN":["1177-1062","1179-2000"],"issn-type":[{"value":"1177-1062","type":"print"},{"value":"1179-2000","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,31]]},"assertion":[{"value":"17 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors, including RQ, FA, and AK, declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"The data are available from the corresponding author on request.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}},{"value":"Conceptualization: RQ and AK. Data curation: RQ and FA. Formal analysis: RQ. Funding acquisition: RQ. Investigation: RQ. Methodology: RQ and AK. Project administration: RQ. Resources: RQ and FA. Supervision: RQ. Validation: RQ and FA. Writing\u2014original draft: RQ, FA, and AK. Writing\u2014review and editing: RQ and FA. All authors have read and approved the final version of the manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Contribution"}},{"value":"Language editing and refinement of the manuscript were supported by Microsoft Copilot, an AI-powered assistant used to enhance clarity, coherence, and readability during the drafting process.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declaration of Generative AI in Scientific Writing"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval and Consent for Publication\/Participation"}}]}}